infectious%20arthritis
INFECTIOUS ARTHRITIS
The classical presentation of infectious arthritis is acute onset of pain, warmth and swelling of a single joint.
The range of motion is usually decreased.
The knee is the most commonly affected but any joint may be involved.
Fever and chills may be present.
More than 1 joint may be involved in patients with pre-existing joint disease, other inflammatory conditions or severe sepsis, and in some patients infected with certain pathogens eg N gonorrheae, N meningitidis and Salmonella spp.
Infectious arthritis must always be a part of the differential diagnosis in a patient with an acute monoarthritis. 

Surgical Intervention

  • Joint drainage is done to decompress the joint and remove pus, and allows debridement as well as specimens to be obtained for biopsy and repeat culture
    • The cornerstone for the treatment of non-gonococcal infectious arthritis
  • Joint drainage may be done via:
    • Needle aspiration
      • Closed-needle aspiration can be considered in patients who are medically unfit to undergo arthrotomy or arthroscopy
      • Usually done for peripheral joints
      • Repeat aspiration daily may be needed for 7-10 days
    • Arthroscopy
      • May be used as an alternative to open surgery
      • Mostly done on the knee, shoulder and wrist
      • Associated with shorter hospital stay
      • Provide better visualization of the joint space for prognostic purposes
    • Open surgical drainage/Arthrotomy
      • Done when full drainage cannot be achieved thru needle aspiration or when there is absence of improvement even with multiple needle aspirations
      • Mostly done for the hips, shoulders and prosthetic joints
  • Delayed joint drainage may lead to permanent joint damage resulting from increased intra-articular pressure
  • All patients with suspected infectious arthritis of a prosthetic joint should be referred to an orthopedic surgeon
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.